Omda (formerly CSAM Health Group) is a Norwegian software company providing digital solutions to the healthcare industry, primarily focusing on medical professionals and emergency responders within the public sector. Their Clinical Trials Platform is part of their Health Analytics division, which offers comprehensive support for clinical research and facilitates safe, accurate, and valuable trials.
Omda was founded in 1999 by Oslo University Hospital and later spun out in 2012. The company has grown significantly since then, expanding its product offerings and geographical reach. Omda now serves over 500 customers in 27 countries, with the Nordic region as its primary market.
Omda has been listed on Euronext Growth since October 2020. While specific funding details are not provided, the company's public listing suggests it has access to capital markets for funding its growth and operations.
Omda's Clinical Trials Platform offers:
Omda emphasizes a culture of innovation, customer-centricity, and continuous improvement. The company values transparency, efficiency, and a strong commitment to customer satisfaction. They aim to provide high-quality, effective solutions that help healthcare professionals achieve better results and improve overall productivity.
Omda's Clinical Trials Platform serves a diverse range of users, including pharmaceutical companies, Contract Research Organizations (CROs), and clinical trial sites. The platform is designed to support multiple stakeholders involved in clinical trials, including clinical operations teams, data managers, and regulatory affairs professionals. User reviews generally highlight the software's ease of use, comprehensive features, and positive impact on managing clinical trials efficiently.
Clinical Trials Platform
By MedSciNet
